Current Environment: Production

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Harvard College

1980, Cambridge, MA

Medical School

Harvard Medical School

1985, Boston, MA

Internship

Boston Children's Hospital

1986, Boston, MA

Residency

Boston Children's Hospital

1988, Boston, MA

Fellowship

Cardiac Electrophysiology

Boston Children's Hospital

1991, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

  1. Cardiac implantable electronic devices in pediatric and congenital populations. Prog Cardiovasc Dis. 2025 May 14. View Cardiac implantable electronic devices in pediatric and congenital populations. Abstract

  2. Electrocardiogram-based deep learning to predict left ventricular systolic dysfunction in paediatric and adult congenital heart disease in the USA: a multicentre modelling study. Lancet Digit Health. 2025 Apr; 7(4):e264-e274. View Electrocardiogram-based deep learning to predict left ventricular systolic dysfunction in paediatric and adult congenital heart disease in the USA: a multicentre modelling study. Abstract

  3. Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease. Eur Heart J. 2025 Mar 03; 46(9):856-868. View Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease. Abstract

  4. Expert-Level Automated Diagnosis of the Pediatric ECG Using a Deep Neural Network. JACC Clin Electrophysiol. 2025 Mar 01. View Expert-Level Automated Diagnosis of the Pediatric ECG Using a Deep Neural Network. Abstract

  5. Artificial Intelligence-Enabled Electrocardiogram Predicts Sudden Cardiac Death in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2025 Mar; 11(3):593-595. View Artificial Intelligence-Enabled Electrocardiogram Predicts Sudden Cardiac Death in Repaired Tetralogy of Fallot. Abstract

  6. Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19; 84(21):2102-2112. View Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. Abstract

  7. Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2024 Dec; 10(12):2600-2612. View Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot. Abstract

  8. Efficacy and safety of early postoperative ablation in patients with congenital heart disease. Heart Rhythm. 2025 May; 22(5):1330-1336. View Efficacy and safety of early postoperative ablation in patients with congenital heart disease. Abstract

  9. Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease. J Am Coll Cardiol. 2024 Aug 27; 84(9):815-828. View Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease. Abstract

  10. Pediatric Electrocardiogram-Based Deep Learning to Predict Secundum Atrial Septal Defects. Pediatr Cardiol. 2025 Jun; 46(5):1235-1240. View Pediatric Electrocardiogram-Based Deep Learning to Predict Secundum Atrial Septal Defects. Abstract

  11. Comparative utility of omnipolar and bipolar electroanatomic mapping methods to detect and localize dual nodal substrate in patients with atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol. 2024 Oct; 67(7):1579-1591. View Comparative utility of omnipolar and bipolar electroanatomic mapping methods to detect and localize dual nodal substrate in patients with atrioventricular nodal reentrant tachycardia. Abstract

  12. Limited Relationship Between Echocardiographic Measures and Electrocardiographic Markers of Left Ventricular Size in Healthy Children. Pediatr Cardiol. 2024 Jun; 45(5):1055-1063. View Limited Relationship Between Echocardiographic Measures and Electrocardiographic Markers of Left Ventricular Size in Healthy Children. Abstract

  13. Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling. Circulation. 2024 03 19; 149(12):917-931. View Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling. Abstract

  14. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. J Cardiovasc Electrophysiol. 2023 12; 34(12):2545-2551. View Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. Abstract

  15. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 12; 82(11):1108-1120. View Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review. Abstract

  16. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 12; 82(11):1121-1130. View Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review. Abstract

  17. Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. Europace. 2023 05 19; 25(5). View Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. Abstract

  18. Insight into the Role of the Child Opportunity Index on Surgical Outcomes in Congenital Heart Disease. J Pediatr. 2023 08; 259:113464. View Insight into the Role of the Child Opportunity Index on Surgical Outcomes in Congenital Heart Disease. Abstract

  19. Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. Heart Rhythm. 2023 07; 20(7):1011-1017. View Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. Abstract

  20. Conduction mapping during complex congenital heart surgery: Creating a predictive model of conduction anatomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1618-1628. View Conduction mapping during complex congenital heart surgery: Creating a predictive model of conduction anatomy. Abstract

  21. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Ann Pediatr Cardiol. 2022 May-Jun; 15(3):323-346. View 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Abstract

  22. Pediatric Electrophysiology Device Needs: A Survey from the Pediatric and Congenital Electrophysiology Society Taskforce on Pediatric-Specific Devices. J Am Heart Assoc. 2022 11 15; 11(22):e026904. View Pediatric Electrophysiology Device Needs: A Survey from the Pediatric and Congenital Electrophysiology Society Taskforce on Pediatric-Specific Devices. Abstract

  23. Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. J Am Heart Assoc. 2022 06 21; 11(12):e022799. View Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. Abstract

  24. Intraoperative conduction mapping in complex congenital heart surgery. JTCVS Tech. 2022 Apr; 12:159-163. View Intraoperative conduction mapping in complex congenital heart surgery. Abstract

  25. Lead Extraction at a Pediatric/Congenital Heart Disease Center: The Importance of Patient Age at Implant. JACC Clin Electrophysiol. 2022 03; 8(3):343-353. View Lead Extraction at a Pediatric/Congenital Heart Disease Center: The Importance of Patient Age at Implant. Abstract

  26. Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices. Pediatr Cardiol. 2022 Apr; 43(4):784-789. View Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices. Abstract

  27. Pediatric T-wave memory after accessory pathway ablation in Wolff-Parkinson-White syndrome. Heart Rhythm. 2022 03; 19(3):459-465. View Pediatric T-wave memory after accessory pathway ablation in Wolff-Parkinson-White syndrome. Abstract

  28. The Evolution of a Gold Standard in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2021 09; 7(9):1118-1119. View The Evolution of a Gold Standard in Cardiac Electrophysiology. Abstract

  29. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Cardiol Young. 2021 Nov; 31(11):1738-1769. View 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Abstract

  30. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary. Cardiol Young. 2021 Nov; 31(11):1717-1737. View 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary. Abstract

  31. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clin Electrophysiol. 2021 11; 7(11):1437-1472. View 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). Abstract

  32. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Heart Rhythm. 2021 11; 18(11):1925-1950. View 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Abstract

  33. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Heart Rhythm. 2021 11; 18(11):1888-1924. View 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Abstract

  34. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Indian Pacing Electrophysiol J. 2021 Nov-Dec; 21(6):367-393. View 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Abstract

  35. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary. Indian Pacing Electrophysiol J. 2021 Nov-Dec; 21(6):349-366. View 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary. Abstract

  36. Accessory pathway ablation in Ebstein anomaly: A challenging substrate. Heart Rhythm. 2021 11; 18(11):1844-1851. View Accessory pathway ablation in Ebstein anomaly: A challenging substrate. Abstract

  37. Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 02 16; 77(6):761-771. View Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week. Abstract

  38. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. Abstract

  39. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Abstract

  40. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Abstract

  41. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population. Heart Rhythm. 2020 06; 17(6):984-990. View Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population. Abstract

  42. Outcomes of catheter ablation of anteroseptal and midseptal accessory pathways in pediatric patients. Heart Rhythm. 2020 05; 17(5 Pt A):759-767. View Outcomes of catheter ablation of anteroseptal and midseptal accessory pathways in pediatric patients. Abstract

  43. Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2019 11; 12(11):e007663. View Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Abstract

  44. The Real-World Utility of the LINQ Implantable Loop Recorder in Pediatric and Adult Congenital Heart Patients. JACC Clin Electrophysiol. 2019 02; 5(2):245-251. View The Real-World Utility of the LINQ Implantable Loop Recorder in Pediatric and Adult Congenital Heart Patients. Abstract

  45. Pediatric and congenital electrophysiology society initiative on device needs in pediatric electrophysiology. Heart Rhythm. 2019 04; 16(4):e39-e46. View Pediatric and congenital electrophysiology society initiative on device needs in pediatric electrophysiology. Abstract

  46. Hospital Costs Related to Early Extubation After Infant Cardiac Surgery. Ann Thorac Surg. 2019 05; 107(5):1421-1426. View Hospital Costs Related to Early Extubation After Infant Cardiac Surgery. Abstract

  47. Measuring defibrillator surface potentials: The validation of a predictive defibrillation computer model. Comput Biol Med. 2018 11 01; 102:402-410. View Measuring defibrillator surface potentials: The validation of a predictive defibrillation computer model. Abstract

  48. Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? JACC Clin Electrophysiol. 2018 10; 4(10):1289-1297. View Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? Abstract

  49. Evaluation of left ventricular false tendons in children with idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol. 2018 09; 41(9):1143-1149. View Evaluation of left ventricular false tendons in children with idiopathic left ventricular tachycardia. Abstract

  50. Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation. Congenit Heart Dis. 2018 May; 13(3):419-427. View Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation. Abstract

  51. Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures. Congenit Heart Dis. 2018 Mar; 13(2):222-225. View Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures. Abstract

  52. Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome. J Am Heart Assoc. 2017 Sep 21; 6(9). View Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome. Abstract

  53. Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers. Pacing Clin Electrophysiol. 2017 Sep; 40(9):1017-1026. View Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers. Abstract

  54. Moving the Goalposts: Prevention of Atrial Arrhythmias After Congenital Heart Surgery. Circ Arrhythm Electrophysiol. 2016 12; 9(12). View Moving the Goalposts: Prevention of Atrial Arrhythmias After Congenital Heart Surgery. Abstract

  55. Keeping time in the chest. Heart Rhythm. 2017 02; 14(2):300-301. View Keeping time in the chest. Abstract

  56. Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. J Thorac Cardiovasc Surg. 2017 03; 153(3):638-645.e2. View Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. Abstract

  57. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart Rhythm. 2017 01; 14(1):e41-e44. View Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Abstract

  58. Trends in Congenital Heart Disease: The Next Decade. Circulation. 2016 Jun 21; 133(25):2716-33. View Trends in Congenital Heart Disease: The Next Decade. Abstract

  59. Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Heart Rhythm. 2016 05; 13(5):1006-1009. View Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Abstract

  60. Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Cardiol Young. 2016 Aug; 26(6):1039-43. View Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Abstract

  61. Sudden Cardiac Death in the Young. Circulation. 2016 Mar 08; 133(10):1006-26. View Sudden Cardiac Death in the Young. Abstract

  62. Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Heart Rhythm. 2016 06; 13(6):1228-37. View Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Abstract

  63. Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign? Int J Cardiol. 2016 Mar 01; 206:158-63. View Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign? Abstract

  64. Arrhythmias in Adult Congenital Heart Disease: Diagnosis and Management. Cardiol Clin. 2015 Nov; 33(4):571-88, viii. View Arrhythmias in Adult Congenital Heart Disease: Diagnosis and Management. Abstract

  65. Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1065-72. View Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects. Abstract

  66. Reply to the Editor--Detection of long QT syndrome in the community. Heart Rhythm. 2015 Jul; 12(7):e67-8. View Reply to the Editor--Detection of long QT syndrome in the community. Abstract

  67. A method to account for variation in congenital heart surgery charges. Ann Thorac Surg. 2015 Mar; 99(3):939-46. View A method to account for variation in congenital heart surgery charges. Abstract

  68. Mechanism and ablation of arrhythmia following total cavopulmonary connection. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):318-25. View Mechanism and ablation of arrhythmia following total cavopulmonary connection. Abstract

  69. Neonatal ECG screening: opinions and facts. Heart Rhythm. 2015 Mar; 12(3):610-611. View Neonatal ECG screening: opinions and facts. Abstract

  70. My approach to Wolff-Parkinson-White syndrome. Trends Cardiovasc Med. 2015 Apr; 25(3):261-2. View My approach to Wolff-Parkinson-White syndrome. Abstract

  71. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014 Oct; 30(10):e1-e63. View PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Abstract

  72. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1057-63. View Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. Abstract

  73. Rationale and objectives for ECG screening in infancy. Heart Rhythm. 2014 Dec; 11(12):2316-21. View Rationale and objectives for ECG screening in infancy. Abstract

  74. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014 09; 16(9):1257-83. View EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Abstract

  75. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014 Oct; 11(10):e166-96. View EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Abstract

  76. Searching for a Rosetta Stone: genetic data and clinical patient management. Heart Rhythm. 2014 Oct; 11(10):1714-5. View Searching for a Rosetta Stone: genetic data and clinical patient management. Abstract

  77. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e81-e101. View PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Abstract

  78. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e102-65. View PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Abstract

  79. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014 Jul 01; 307(1):H110-7. View Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Abstract

  80. Guidelines for management of asymptomatic ventricular pre-excitation: brave new world or Pandora's box? Circ Arrhythm Electrophysiol. 2014 Apr; 7(2):187-9. View Guidelines for management of asymptomatic ventricular pre-excitation: brave new world or Pandora's box? Abstract

  81. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm. 2014 Feb; 11(2):182-6. View Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Abstract

  82. Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):127-33. View Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Abstract

  83. Post-mortem genetic testing in a family with long-QT syndrome and hypertrophic cardiomyopathy. Cardiovasc Pathol. 2014 Mar-Apr; 23(2):107-9. View Post-mortem genetic testing in a family with long-QT syndrome and hypertrophic cardiomyopathy. Abstract

  84. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Electrophysiol. 2013 Oct; 6(5):1032-40. View Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Abstract

  85. Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc. 2013 Sep 19; 2(5):e000325. View Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. Abstract

  86. The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Ann Thorac Surg. 2013 Sep; 96(3):904-9. View The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Abstract

  87. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014 Feb; 16(2):277-83. View The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Abstract

  88. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol. 2013 Oct 09; 168(4):3940-3. View Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Abstract

  89. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol. 2013 Sep; 36(9):1117-22. View The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Abstract

  90. COMPASS: a novel risk-adjustment model for catheter ablation in pediatric and congenital heart disease patients. Congenit Heart Dis. 2013 Sep-Oct; 8(5):393-405. View COMPASS: a novel risk-adjustment model for catheter ablation in pediatric and congenital heart disease patients. Abstract

  91. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J Cardiovasc Electrophysiol. 2013 Jun; 24(6):640-8. View Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. Abstract

  92. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013 May; 36(5):607-11. View Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Abstract

  93. Multiple accessory pathways in the young: the impact of structural heart disease. Am Heart J. 2013 Jan; 165(1):87-92. View Multiple accessory pathways in the young: the impact of structural heart disease. Abstract

  94. Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Pacing Clin Electrophysiol. 2012 Dec; 35(12):1487-93. View Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Abstract

  95. If the shoe fits: antitachycardia pacing in children and patients with congenital heart disease. Heart Rhythm. 2012 Nov; 9(11):1835-6. View If the shoe fits: antitachycardia pacing in children and patients with congenital heart disease. Abstract

  96. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail. 2012 Jul 01; 5(4):462-6. View Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Abstract

  97. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012 Jun; 9(6):1006-24. View PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Abstract

  98. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation. 2012 May 29; 125(21):2621-9. View Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Abstract

  99. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics. 2012 Apr; 129(4):e999-1010. View Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Abstract

  100. Follow-up of a modified Fontan randomized trial for intraatrial reentrant tachycardia prophylaxis. Congenit Heart Dis. 2012 May-Jun; 7(3):219-25. View Follow-up of a modified Fontan randomized trial for intraatrial reentrant tachycardia prophylaxis. Abstract

  101. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol. 2011 Oct 25; 58(18):1903-9. View Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. Abstract

  102. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol. 2011 Sep; 22(9):1013-7. View The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. Abstract

  103. Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol. 2011 May 15; 107(10):1535-40. View Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Abstract

  104. Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Heart Rhythm. 2011 Apr; 8(4):519-25. View Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Abstract

  105. Development of an ovine model of pediatric complete heart block. J Surg Res. 2011 Apr; 166(2):e103-8. View Development of an ovine model of pediatric complete heart block. Abstract

  106. The risk of ionizing radiation in electrophysiology studies and ablations. Pacing Clin Electrophysiol. 2011 Mar; 34(3):261-3. View The risk of ionizing radiation in electrophysiology studies and ablations. Abstract

  107. Children are not just small adults. Heart Rhythm. 2011 Jan; 8(1):29-30. View Children are not just small adults. Abstract

  108. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2010 Oct; 3(5):437-44. View Lead extraction in pediatric and congenital heart disease patients. Abstract

  109. Epicardial left atrial appendage and biatrial appendage accessory pathways. Heart Rhythm. 2010 Dec; 7(12):1740-5. View Epicardial left atrial appendage and biatrial appendage accessory pathways. Abstract

  110. Needle in a haystack: modeling the incidence of sudden cardiac arrest in healthy children. Circulation. 2010 Mar 23; 121(11):1283-5. View Needle in a haystack: modeling the incidence of sudden cardiac arrest in healthy children. Abstract

  111. Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Heart Rhythm. 2010 May; 7(5):692-8. View Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Abstract

  112. Atrial remodeling after the Fontan operation. Am J Cardiol. 2009 Dec 15; 104(12):1737-42. View Atrial remodeling after the Fontan operation. Abstract

  113. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7(2):193-8. View System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Abstract

  114. Management of asymptomatic Wolff-Parkinson-White syndrome. Heart. 2009 Oct; 95(19):1628-34. View Management of asymptomatic Wolff-Parkinson-White syndrome. Abstract

  115. The Meaning of Lethal Events in Infants With Long QT Syndrome. J Am Coll Cardiol. 2009 Aug 25; 54(9):838-9. View The Meaning of Lethal Events in Infants With Long QT Syndrome. Abstract

  116. Brugada and short QT syndromes. Pacing Clin Electrophysiol. 2009 Jul; 32 Suppl 2:S58-62. View Brugada and short QT syndromes. Abstract

  117. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol. 2009 Jun; 32(6):779-85. View Permanent atrial pacing lead implant route after Fontan operation. Abstract

  118. Procedural innovation and ablation of pediatric SVT. J Cardiovasc Electrophysiol. 2009 Jun; 20(6):643-4. View Procedural innovation and ablation of pediatric SVT. Abstract

  119. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease. Circ Arrhythm Electrophysiol. 2008 Oct; 1(4):307-16; discussion 316. View Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease. Abstract

  120. Predictive modeling of defibrillation using hexahedral and tetrahedral finite element models: recent advances. J Electrocardiol. 2008 Nov-Dec; 41(6):483-6. View Predictive modeling of defibrillation using hexahedral and tetrahedral finite element models: recent advances. Abstract

  121. Ascending aortic dilation in patients with congenital complete heart block. Heart Rhythm. 2008 Dec; 5(12):1704-8. View Ascending aortic dilation in patients with congenital complete heart block. Abstract

  122. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):58-65. View Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. Abstract

  123. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol. 2009 Nov 12; 137(3):260-6. View Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Abstract

  124. Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Heart Rhythm. 2008 Oct; 5(10):1391-5. View Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Abstract

  125. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008 Apr 29; 51(17):1685-91. View Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. Abstract

  126. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Heart Rhythm. 2008 Apr; 5(4):545-50. View Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Abstract

  127. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008 Mar; 31(3):338-43. View How revealing are insertable loop recorders in pediatrics? Abstract

  128. Hypotension from epinephrine in a food-allergic patient with long QT syndrome. Ann Allergy Asthma Immunol. 2008 Feb; 100(2):174-5. View Hypotension from epinephrine in a food-allergic patient with long QT syndrome. Abstract

  129. A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm. 2008 Apr; 5(4):565-72. View A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Abstract

  130. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008 Jan 01; 117(1):85-92. View Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Abstract

  131. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2008 Jan; 21(1):65-8. View Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. Abstract

  132. Imaging artifacts of medical instruments in ultrasound-guided interventions. J Ultrasound Med. 2007 Oct; 26(10):1303-22. View Imaging artifacts of medical instruments in ultrasound-guided interventions. Abstract

  133. Atypical atrial tachycardias in patients with congenital heart disease. Heart Rhythm. 2008 Feb; 5(2):315-7. View Atypical atrial tachycardias in patients with congenital heart disease. Abstract

  134. Successful cryoablation of ventricular tachycardia arising from the proximal right bundle branch in a child. Heart Rhythm. 2008 Jan; 5(1):142-4. View Successful cryoablation of ventricular tachycardia arising from the proximal right bundle branch in a child. Abstract

  135. Evaluation of different meshing algorithms in the computation of defibrillation thresholds in children. Annu Int Conf IEEE Eng Med Biol Soc. 2007; 2007:1422-5. View Evaluation of different meshing algorithms in the computation of defibrillation thresholds in children. Abstract

  136. Cost effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2007 Jan; 28(1):137; author reply137-9. View Cost effectiveness of neonatal ECG screening for the long QT syndrome. Abstract

  137. Cardiac conduction through engineered tissue. Am J Pathol. 2006 Jul; 169(1):72-85. View Cardiac conduction through engineered tissue. Abstract

  138. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):754-9. View Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. Abstract

  139. Producing diffuse ultrasound reflections from medical instruments using a quadratic residue diffuser. Ultrasound Med Biol. 2006 May; 32(5):721-7. View Producing diffuse ultrasound reflections from medical instruments using a quadratic residue diffuser. Abstract

  140. Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease. J Cardiovasc Electrophysiol. 2006 Apr; 17(4):359-65. View Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease. Abstract

  141. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm. 2006 Mar; 3(3):253-8. View Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Abstract

  142. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006 Jan; 17(1):41-6. View A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. Abstract

  143. Image based modeling of defibrillation in children. Conf Proc IEEE Eng Med Biol Soc. 2006; 2006:2564-7. View Image based modeling of defibrillation in children. Abstract

  144. Virtual reality in interventional electrophysiology. Circulation. 2005 Dec 13; 112(24):3677-9. View Virtual reality in interventional electrophysiology. Abstract

  145. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005 Nov 29; 112(22):3470-7. View Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Abstract

  146. Modification of the slow pathway in atrioventricular nodal reentrant tachycardia: no pain, no gain. Heart Rhythm. 2005 Nov; 2(11):1186-7. View Modification of the slow pathway in atrioventricular nodal reentrant tachycardia: no pain, no gain. Abstract

  147. Three-dimensional echo-guided beating heart surgery without cardiopulmonary bypass: atrial septal defect closure in a swine model. J Thorac Cardiovasc Surg. 2005 Nov; 130(5):1348-57. View Three-dimensional echo-guided beating heart surgery without cardiopulmonary bypass: atrial septal defect closure in a swine model. Abstract

  148. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005 Oct; 14(1):27-36. View Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. Abstract

  149. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005 Jul; 2(7):700-5. View Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Abstract

  150. Inability to cannulate the coronary sinus in patients with supraventricular arrhythmias: congenital and acquired coronary sinus atresia. J Interv Card Electrophysiol. 2005 Mar; 12(2):123-7. View Inability to cannulate the coronary sinus in patients with supraventricular arrhythmias: congenital and acquired coronary sinus atresia. Abstract

  151. Risk stratification for prophylactic ablation in asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. 2005 Jan 06; 352(1):92-3; author reply 92-3. View Risk stratification for prophylactic ablation in asymptomatic Wolff-Parkinson-White syndrome. Abstract

  152. Identification of cardiac rhythm features by mathematical analysis of vector fields. IEEE Trans Biomed Eng. 2005 Jan; 52(1):19-29. View Identification of cardiac rhythm features by mathematical analysis of vector fields. Abstract

  153. Three-dimensional echocardiography-guided beating-heart surgery without cardiopulmonary bypass: a feasibility study. J Thorac Cardiovasc Surg. 2004 Oct; 128(4):579-87. View Three-dimensional echocardiography-guided beating-heart surgery without cardiopulmonary bypass: a feasibility study. Abstract

  154. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004 Sep; 1(3):301-8. View Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Abstract

  155. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):150-9. View Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Abstract

  156. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):168-73. View Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Abstract

  157. Three-dimensional echocardiography-guided atrial septectomy: an experimental study. J Thorac Cardiovasc Surg. 2004 Jul; 128(1):53-9. View Three-dimensional echocardiography-guided atrial septectomy: an experimental study. Abstract

  158. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol. 2004 Jun 01; 93(11):1449-52, A12. View Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Abstract

  159. Ablation of atrioventricular nodal reentrant tachycardia in tricuspid atresia. J Cardiovasc Electrophysiol. 2004 Jun; 15(6):719-22. View Ablation of atrioventricular nodal reentrant tachycardia in tricuspid atresia. Abstract

  160. Comparative psychometric analysis of vector and isochrone cardiac activation maps. IEEE Trans Biomed Eng. 2004 May; 51(5):847-55. View Comparative psychometric analysis of vector and isochrone cardiac activation maps. Abstract

  161. So far, so good... J Cardiovasc Electrophysiol. 2004 Mar; 15(3):284-5. View So far, so good... Abstract

  162. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg. 2004 Mar; 127(3):721-9. View Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. Abstract

  163. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004 Jan; 15(1):72-6. View Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. Abstract

  164. Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Am J Cardiol. 2003 Oct 15; 92(8):947-50. View Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Abstract

  165. Estimation of cardiac conduction velocities using small data sets. Ann Biomed Eng. 2003 Mar; 31(3):250-61. View Estimation of cardiac conduction velocities using small data sets. Abstract

  166. Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):119-25. View Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. Abstract

  167. Application of robotics in congenital cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003; 6:72-83. View Application of robotics in congenital cardiac surgery. Abstract

  168. Estimation of entrainment response using electrograms from remote sites: validation in animal and computer models of reentrant tachycardia. J Cardiovasc Electrophysiol. 2003 Jan; 14(1):52-61. View Estimation of entrainment response using electrograms from remote sites: validation in animal and computer models of reentrant tachycardia. Abstract

  169. Heart rate control and mechanical cardiopulmonary coupling to assess central volume: a systems analysis. Am J Physiol Regul Integr Comp Physiol. 2002 Nov; 283(5):R1210-20. View Heart rate control and mechanical cardiopulmonary coupling to assess central volume: a systems analysis. Abstract

  170. Circadian and seasonal variation of malignant arrhythmias in a pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2002 Oct; 13(10):1009-14. View Circadian and seasonal variation of malignant arrhythmias in a pediatric and congenital heart disease population. Abstract

  171. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002 Aug 01; 90(3):338-40. View Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Abstract

  172. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002 Jun 05; 39(11):1827-35. View Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. Abstract

  173. Arrhythmias in adults with congenital heart disease. Heart. 2002 Apr; 87(4):383-9. View Arrhythmias in adults with congenital heart disease. Abstract

  174. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1789-94. View Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Abstract

  175. Postoperative ectopic atrial tachycardia in children with congenital heart disease. Am J Cardiol. 2001 Nov 15; 88(10):1169-72. View Postoperative ectopic atrial tachycardia in children with congenital heart disease. Abstract

  176. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001 Oct; 12(10):1097-101. View Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. Abstract

  177. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res. 2001 Jun; 50(3):463-73. View Induction of atrial tachycardia and fibrillation in the mouse heart. Abstract

  178. Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. J Cardiovasc Electrophysiol. 2001 Jun; 12(6):671-9. View Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. Abstract

  179. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001 May; 37(6):1665-76. View Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. Abstract

  180. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001 Apr 24; 103(16):2060-5. View Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Abstract

  181. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):28-41. View Long-term results of the lateral tunnel Fontan operation. Abstract

  182. Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. J Cardiovasc Electrophysiol. 2001 Jan; 12(1):17-25. View Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. Abstract

  183. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000 Nov 01; 86(9):969-74. View Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Abstract

  184. Estimation of atrial response to entrainment pacing using electrograms recorded from remote sites. J Cardiovasc Electrophysiol. 2000 Nov; 11(11):1215-22. View Estimation of atrial response to entrainment pacing using electrograms recorded from remote sites. Abstract

  185. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol. 2000 Aug; 279(2):H733-40. View Phenotypic screening for heart rate variability in the mouse. Abstract

  186. Focal ablation of chaotic atrial rhythm in an infant with cardiomyopathy. J Cardiovasc Electrophysiol. 2000 May; 11(5):577-81. View Focal ablation of chaotic atrial rhythm in an infant with cardiomyopathy. Abstract

  187. Sudden death in patients after transcatheter device implantation for congenital heart disease. Am J Cardiol. 2000 Apr 15; 85(8):992-5. View Sudden death in patients after transcatheter device implantation for congenital heart disease. Abstract

  188. Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J Pediatr. 2000 Apr; 136(4):481-9. View Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. Abstract

  189. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999 Aug; 10(8):1033-44. View Value of programmed ventricular stimulation in patients with congenital heart disease. Abstract

  190. Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Pacing Clin Electrophysiol. 1998 May; 21(5):1098-104. View Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Abstract

  191. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr. 1997 Dec; 131(6):878-87. View Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. Abstract

  192. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997 Oct; 30(4):1032-8. View Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. Abstract

  193. Model dependency of multivariate autoregressive spectral analysis. IEEE Eng Med Biol Mag. 1997 Sep-Oct; 16(5):74-85. View Model dependency of multivariate autoregressive spectral analysis. Abstract

  194. Radiofrequency ablation of intraatrial reentrant tachycardia after surgery for congenital heart disease. Pacing Clin Electrophysiol. 1997 Aug; 20(8 Pt 2):2112-7. View Radiofrequency ablation of intraatrial reentrant tachycardia after surgery for congenital heart disease. Abstract

  195. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1997 Jul; 8(7):812-7. View High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. Abstract

  196. Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1654-61. View Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Abstract

  197. Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature. Pacing Clin Electrophysiol. 1997 May; 20(5 Pt 1):1283-91. View Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature. Abstract

  198. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol. 1997 Apr; 29(5):1046-53. View Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. Abstract

  199. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997 Mar; 8(3):259-70. View Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. Abstract

  200. Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):51-9. View Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Abstract

  201. Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage. Circulation. 1996 Aug 01; 94(3):253-7. View Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage. Abstract

  202. Baroreflex gain: characterization using autoregressive moving average analysis. Am J Physiol. 1996 Apr; 270(4 Pt 2):H1240-9. View Baroreflex gain: characterization using autoregressive moving average analysis. Abstract

  203. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996 Apr; 27(5):1246-50. View Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. Abstract

  204. Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Am J Cardiol. 1996 Mar 15; 77(8):655-8. View Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Abstract

  205. High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. J Electrocardiol. 1996; 29 Suppl:234-40. View High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. Abstract

  206. Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol. 1995 Dec; 6(12):1129-48. View Mechanisms and therapy of complex arrhythmias in pediatric patients. Abstract

  207. Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol. 1995 Jun 15; 75(17):1278-81. View Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Abstract

  208. Respiratory sinus arrhythmia: time domain characterization using autoregressive moving average analysis. Am J Physiol. 1995 Jun; 268(6 Pt 2):H2232-8. View Respiratory sinus arrhythmia: time domain characterization using autoregressive moving average analysis. Abstract

  209. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995 May; 18(5 Pt 1):1005-16. View Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Abstract

  210. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995 Feb 01; 91(3):707-14. View Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Abstract

  211. Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age. Am J Cardiol. 1994 Nov 01; 74(9):944-7. View Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age. Abstract

  212. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol. 1994 Aug 15; 74(4):412-3. View Staged pacing therapy for congenital complete heart block in premature infants. Abstract

  213. Comparison of intraarterial with continuous noninvasive blood pressure measurement in postoperative pediatric patients. J Clin Monit. 1994 Jan; 10(1):11-20. View Comparison of intraarterial with continuous noninvasive blood pressure measurement in postoperative pediatric patients. Abstract

  214. Blood pressure modulation by central venous pressure and respiration. Buffering effects of the heart rate reflexes. Circulation. 1994 Jan; 89(1):169-79. View Blood pressure modulation by central venous pressure and respiration. Buffering effects of the heart rate reflexes. Abstract

  215. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol. 1993 Jul; 22(1):207-15. View Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. Abstract

  216. Mild hypovolemic stress alters autonomic modulation of heart rate. Hypertension. 1993 Feb; 21(2):236-47. View Mild hypovolemic stress alters autonomic modulation of heart rate. Abstract

  217. Closure of congenital and acquired intracardiac shunts using transcatheter techniques: a review. Indian Heart J. 1992 May-Jun; 44(3):125-31. View Closure of congenital and acquired intracardiac shunts using transcatheter techniques: a review. Abstract

  218. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg. 1989 May; 97(5):785-97. View A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. Abstract

  219. The human tumor colony forming assay: review and clinical applications. R I Med J (1976). 1985 Aug; 68(8):361-6. View The human tumor colony forming assay: review and clinical applications. Abstract

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Chemical Engineering

Columbia University, School of Engineering & Applied Sciences

1996, New York, NY

Medical School

New York University School of Medicine

2000, New York, NY

Internship

Pediatrics

Children's Hospital of New York

2001, New York, NY

Residency

Pediatrics

Children's Hospital of New York

2003, New York, NY

Fellowship

Pediatric Cardiology, Outpatient and Non-Invasive Imaging

Boston Children's Hospital

2007, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Georgetown University

1971, Washington, DC

Medical School

University of Louisville

1975, Lousville, KY

Internship

Good Samaritan Hospital

1976, Portland, OR

Residency

Pediatrics

University of Oregon Health Science Centers

1978, Portland, OR

Fellowship

Pediatric Cardiology

Boston Children's Hospital

1981, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Brown University

1992, Providence, RI

Medical School

University of Texas Southwestern Medical Center

1998, Dallas, TX

Residency

Pediatrics

Boston Floating Hospital for Children

2001, Boston, MA

Residency

Chief Resident, Pediatrics

Boston Floating Hospital for Children

2002, Boston, MA

Fellowship

Cardiology

Children's Hospital of Philadelphia

2005, Philadelphia, PA

Fellowship

Senior Fellow, Echocardiology

Boston Children's Hospital

2006, Boston, MA

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Brandeis University

1999, Waltham, MA

Graduate School

Esther Boyer College of Music, Temple University

2002, Philadelphia, PA

Medical School

Temple University School of Medicine

2006, Philadelphia, PA

Internship

University of California, Los Angeles

2006, Los Angeles, CA

Residency

University of California, Los Angeles

2009, Los Angeles, CA

Residency

Chief Resident

University of California, Los Angeles

2009, Los Angeles, CA

Fellowship

Cardiology

Boston Children's Hospital

2013, Boston, MA

Fellowship

Chief Fellow, Cardiology

Boston Children's Hospital

2013, Boston, MA

Fellowship

Senior Fellow, Cardiac Imaging

Boston Children's Hospital

2014, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Harvard College

1988, Cambridge, MA

Medical School

Harvard College

1992, Boston, MA

Internship

Boston Children's Hospital

1993, Boston, MA

Residency

Boston Children's Hospital

1995, Boston, MA

Fellowship

Boston Children's Hospital

1998, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Yale University

1988, New Haven, CT

Medical School

Harvard Medical School

1993, Boston, MA

Internship

Boston Children's Hospital

1994, Boston, MA

Residency

Boston Children's Hospital

1996, Boston, MA

Fellowship

Boston Children's Hospital

1999, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Undergraduate School

Boston College

2010, Boston, MA

Medical School

Yale School of Medicine

2014, New Haven, CT

Internship

Yale-New Haven Hospital

2015, New Haven, CT

Residency

Yale-New Haven Hospital

2017, New Haven, CT

Fellowship

Boston Children's Hospital

2020, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Medical School

Institute of Medical Sciences

1992, Varanasi, India

Residency

Pediatrics

Institute of Medical Sciences

1995, Varanasi, India

Residency

Senior Resident, Pediatrics

Indraprastha Apollo Hospitals

1996, New Delhi, India

Residency

Pediatrics

New York Medical College

1999, New York, NY

Fellowship

Pediatric Cardiology

Columbia University

2002, New York, NY

Fellowship

Senior Fellow, Cardiac MRI

Boston Children's Hospital

2003, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

American Board of Pediatrics (Cardiology) | Education

Medical School

Tufts University School of Medicine

2010, Boston, MA

Residency

Children's Memorial Hospital

2013, Chicago, IL

Fellowship

Boston Children's Hospital

2017, Boston, MA

American Board of Pediatrics (Cardiology) | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services